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Optical coherence tomography (OCT) was introduced about two decades ago and has
revolutionized ophthalmic practice in recent years. It is a noninvasive noncontact imaging
modality that provides a high-resolution cross-sectional image of the cornea, retina,
choroid and optic nerve head, analogous to that of the histological section. Advances in
OCT technology in signal detection technique from time-domain (TD) to spectral-domain
(SD) detection have given us the potential to study various retinal layers more precisely
and in less time. SD-OCT better delineates structural changes and fine lesions in the in-
dividual retinal layers. Thus, we have gained substantial information about the pathologic
and structural changes in ocular conditions with primary or secondary retinal involve-
ment. This review we discuss the clinical application of currently available SD-OCT in
various retinal pathologies. Furthermore, highlights the benefits of SD-OCT over TD. With
the introduction of enhanced depth imaging and swept e source OCT visualization of the
choroid and choriocapillaris has become possible. Therefore, OCT has become an indis-
pensable ancillary test in the diagnosis and management of diseases involving the retina
and/or the choroid. As OCT technology continues to develop further it will provide new
insights into the retinal and choroidal structure and the pathogenesis of posterior segment
of the eye.Optical coherence tomography (OCT) has emerged as an macular and optic nerve head pathologies [1e5]. Since itsimportant imaging modality in the evaluation and manage-
ment of retinal disease. The noninvasive nature of the test
and the ability to image intra-ocular structures in vivo with
resolution approaching that of histological sections has made
OCT particularly useful in the detection and quantification ofthalmology, University of
9361; fax: þ1 904 2449391
Chalam).
g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).introduction in the late 1990s for clinical application in the
imaging of retinal and optic nerve disorders, OCT has shown
major improvements in technologywith increasing resolution
of the images.Florida College of Medicine, 580 W 8th Street, Tower 2, 3rd Floor,
.
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echo imaging, but instead of sound waves, it uses near-
infrared light to produce cross-sectional or three-
dimensional (3D) images of the retina [1e8]. The images are
generated through the measurement of magnitude and echo
time delay of back scattered light from an optical beam across
the retina. Since direct detection of light echoes is not possible
due to the high velocity of light, measurements are done
correlating sample reflections from a reference mirror using a
Michelson interferometer. In this arrangement of the system,
referred to as the time-domain (TD) OCT, one arm of the
interferometer directs lights and collects the back scattered
signal from the object of interest. A second reference armwith
a reflecting mirror is mechanically controlled to vary the time
delay andmeasure interference. The combination of reflected
light from the sample arm and reference light from the
reference arm gives rise to an interference pattern, given that
light from both arms has traveled similar optical distance
within the coherence length. Areas of the sample that reflect
back a lot of light will create greater interference than areas
that do not. Any light that is outside the short coherence
length will not interfere. This reflectivity profile, called an A-
scan contains information about the spatial dimensions and
location of structures within the item of interest. A cross-
sectional tomographic B-scan is achieved by laterally
combining a series of A-scans.
However, conventional TD-OCT has several limitations.
Because there is a time delay involved during the axial
translation of the reference mirror, the number of A scans
acquired is limited, resulting in a B-scan with poor resolution.
Another related problem is the lack of registration, poor point
to point correlation between an OCT B-scan and the patient's
fundus. A final critical limitation related to the slow-speed of
TD-OCT is poor sampling density. Large amount of data is
interpolated by sampling only a fraction of the mapped area.
Within the past decade, a new generation of OCT tech-
nology known as “SD-OCT” or “Fourier domain” OCT has
evolved. In SD-OCT, light echoes are detected by measuring
the interference signal as a function of wavelength by the use
of an interferometer with a stationary reference arm [9]. The
measurement of light echoes simultaneously allows high
speed scanning with scan rates 50e100 times faster than
conventional TD-OCT. This results in improved resolution of
the B-scan images (the axial resolution on SD-OCT is 4e7 m asFig. 1 e Retinal cross-sectional image from the same subject on t
spectral-domain Spectralis optical coherence tomography (right).compared to 10 m on the Stratus TD-OCT) [6e8]. Spectralis
(Heidelberg Engineering, Vista, CA/Germany.), one of the
commercially available SD-OCT, also incorporates the Tru-
track™ technology, which significantly reduces image cor-
ruption due to motion artifacts and provides the opportunity
to correlate quantitatively the same areas of retinal pathology
at sequential time points [Fig. 1].Imaging on spectral-domain optical coherence
tomography
Retinal cross-sectional imaging on Stratus OCT is dominated
by signals from the nerve fiber layer (NFL), the outer segment-
inner segment line of the photoreceptors (ellipsoid zone) and
the retinal pigment epithelium (RPE). Low-backscattering
ganglion cell layer (GCL), external limiting membrane (ELM)
are poorly resolved as well as the boundaries between the
transparent and highly scattering layers such as the NFL, the
inner plexiform layer (IPL), the outer plexiform layer (OPL),
the ellipsoid zone (also known as IS-OS line) and the RPE
[Fig. 2].
The demonstrated improvement in speed with SD-OCT
allows for a shift from two-dimensional sampling to
comprehensive 3D screening of ocular pathology with OCT [9].
The ultrahigh resolution images enable excellent visualiza-
tion of the architectural morphology of the internal retinal
layers. Although the axial image resolutions are comparable
in the SD and the TD-OCT images, the increase in the trans-
verse pixel density which is possible using SD-OCT signifi-
cantly improves the visualization of retinal architecture. In
addition, intra-retinal interfaces are continuous in the higher
transverse pixel density, SD ultrahigh-resolution OCT image
[9]. On SD-OCT, the following bands are seen outside the
hypo-reflective band of the outer nuclear layer (ONL) by SD-
OCT at the fovea in healthy eyes: (1) A thin, hyper-reflective
band presumably corresponding to the ELM; (2) a slightly
thicker hyper-reflective band presumably corresponding to
the interface of the inner and outer segments of the photo-
receptor layer (PRL); (3) a thin, only occasionally visible, hyper-
reflective band presumably corresponding to the outer
segment-RPE interdigitation; and (4) a broad hyper-reflective
band thought to correspond to the RPE/Bruch's membrane
complex [Fig. 3].ime-domain Stratus optical coherence tomography (left) and
Fig. 2 e Cross-sectional Spectralis optical coherence tomography image of a normal subject revealing all the retinal layers. The
red lines indicate the demarcation of the inner limiting layer (top) and the basement membrane of RPE-Bruch's membrane
complex (bottom).
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by the scan protocols. The standard scan protocol on SD-OCT
machines covers 6 mm  6 mm surface of the retina, gener-
ating 21 B-scan images in 1.4 s, which is comparable to theFig. 3 e Cross-sectional foveal image of a normal subject on
Spectralis optical coherence tomography with delineation of
all the layers of the retina (top). Comparative histological
section of the fovea of a normal human eye (bottom).time required for a single Stratus OCT image. The vertical
distance between consecutive images in the raster is 300 m,
which can be reduced to as low as 50 m in some of the SD-OCT
machines in contrast to the 1.6 mm spacing on Stratus OCT
macular mapping protocol. Increased density of scans has the
potential to detect small focal changes in the parafoveal re-
gion that are not detectable by standard TD-OCT imaging
protocol [8].
Han and Jaffe [10] have reported that in spite of the high-
speed scanning ability and increased resolution of scans,
SD-OCT images are not totally devoid of image artifacts.
Among the artifacts are misidentification of the boundaries of
the inner and outer retina, degraded scan image, off-center
scans not properly centered on an identifiable foveal depres-
sion, and out-of-register artifacts in which the inner retina
was truncated because of a superiorly shifted scan. Clinically
significant artifacts involving the center 1-mm area were seen
in 5.1% of cirrus and 8.0% of Spectralis OCT scans.Macular measurements on spectral-domain
optical coherence tomographyQuantification of macular thickness by OCT in a reproducible,
noninvasive way allows clinicians to monitor the efficacy of
treatment for macular pathology like macular edema. Stratus
OCT provides automated measurements of mean retinal
thickness of the center point and each of four inner and four
outer subfields (inmicrometers), and total macular volume (in
cubic millimeters). An average of all points within the inner
circle of 1-mm diameter is defined as central foveal subfield
(CSF) thickness [Fig. 4]. The OCT software identifies the center
point as the intersection of six radial lines and reports the
center point thickness as the average of the sixmeasurements
of thickness at the center point [8].
There are not only differences in measurement algorithms
ofmacular thicknessbetweenTDandSDOCTsbutalsobetween
OCT machines of the same generation produced by different
manufacturers. Stratus TD-OCT measures retinal thickness
between ILMand the ellipsoid zoneof the photoreceptor. Cirrus
SD-OCT measures macular thickness between ILM and RPE
while Spectralis SD-OCT includesBruch'smembranewithin the
macular thickness [11]. That probably explains why the CSF
Fig. 4 e Spectralis optical coherence tomography showing of the left eye of a normal subjectwithmacular thicknessmap overlay
on the infrared image (left), retinal thickness and volume date for the nine ETDRS subfields (middle) and color map (right).
Fig. 5 e Cross-sectional line scan image on Spectralis optical
coherence tomography showing cystic inner retinal swelling
in patient with diabetic macular edema.
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when compared to that on Stratus OCT [12].
The reliability of change analysis of macular thickness
correlates with the reproducibility of measurements on the
OCT machines [13]. Numerous studies have confirmed the
high reproducibility of macular thickness measurements in
TD-OCT [14e17]. The Diabetic Retinopathy Clinical Research
Network showed that total macular volume has better
reproducibility in cases where there is diffusemacular edema.
Studies done on SD-OCT systems have found higher repro-
ducibility as compared to TD-OCT [18e20]. Leung et al. [19],
have suggested that the higher reproducibility observed in SD-
OCT systems compared with those in TD-OCT may be due to
the higher scan rate of the former, which enables macular
mapping with fewer motion artifacts and thus is more accu-
rate and repeatable segmentation.
Studies have been done to understand how TD-OCT and
SD-OCT data compare to each other in pathological retinal
conditions, as both are frequently used to determine eligi-
bility, treatment and outcome criteria in clinical trials and
clinical practice. Forooghian et al. [21], have reported that
although the two systems appear equally reliable in gener-
ating macular measurements, they may not be used inter-
changeably for clinical practice and research.
Spectral-domain optical coherence tomography
in retinal conditions
Spectral-domain optical coherence tomography in diabetic
macular edema
With the advent of OCT, classification of DME hasmoved from
the traditional one based on angiographic leakage to the one
defining structural changes seen in the retina. Otani and Kishi
[22] described three OCT patterns of DME on Stratus OCT:
simple sponge-like retinal swelling, cystoid macular edema
(CME) and serous retinal detachment. With better delineation
of different retinal layers on SD-OCT, more detailed in vivo
histological changes occurring in DME have been reported.
Leung et al. [19], in their study of 59 patients with DME re-
ported a correlation with the severity of DME to location of
cystic spaces using OPKO/OTI SD-OCT (OPKO-OTI, Miami, FL,USA). For mild retinal edema on fluorescein angiography (FA),
cystic spaces were located only in the OPL. When the cystic
spaces became more pronounced or when they were ill-
defined, they involved both the OPL and ONL. However, they
did not find any significant correlation between the severity of
cystic changes and the source (diffuse or focal) of fluorescein
leakage [Fig. 5].
Macular thickness on OCT is often used as an outcome
measure to assess the effects of various treatments on
Diabetic Macular Edema (DME). However, correlation be-
tween OCT-measured macular thickness and visual acuity
has been variable. Assessing the status of the ellipsoid zone
on SD-OCT is a measure of the health of photoreceptors and
has been shown to correlate with visual acuity in a number
of retinal conditions. Maheshwary et al. [23], have quantified
the percentage disruption of ellipsoid zone in patients with
DME and report that it correlates directly with visual acuity.
However, percentage measurement of disruption of ellip-
soid zone is prone to measurement bias and search is on for
a parameter on SD-OCT, which can act as a surrogate for
visual acuity in these patients. One such parameter is the
use of photoreceptor outer segment (PROS) length. Foor-
ooghian et al. [20], using segmentation algorithm on Cirrus
SD-OCT have reported strong correlation of PROS length
with visual acuity. However, segmentation algorithms to
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studies on more SD-OCT machines in normal and patho-
logical conditions are required before it can be used reliably
in clinical practice.Spectral-domain optical coherence tomography
in age-related macular degeneration
With the advent of high-resolution OCT imaging, new insights
have been achieved in phenotypic variations of age-related
macular degeneration (AMD). A wide range of alterations in
the photoreceptor, RPE-Bruch's membraneechoriocapillaris
complex are being described. In the nonexudative form of
AMD, drusen are seen as dome-shaped elevations of the RPE
band in SD-OCT with more elongated elevations consistentFig. 6 e (A) Fundus photo and corresponding infrared image and cr
tomography of a patient with early age-related macular degenera
optical coherence tomography image of left eye of a patient with
irregularity. (C) Cross-sectional Spectralis optical coherence tomo
related macular degeneration revealing choroidal neovascularizawithsub-RPEdeposits [Fig. 6A].UsingSpectralisOCT,Querques
et al. [24], have revealed that the hitherto less understood
reticulardrusenare actually subretinal drusenoiddeposits and
are distinct from the sub RPE deposits found in soft drusen.
Thinning or thickening of the RPE band in the OCT scan
reflects boundaries of enlarged or attenuated RPE cells.
Schuman et al. [25], in their study of 12 subjects with drusen
using SD-OCT measured the PRL thickness in areas overlying
drusen (size more than 125 m) and have reported that there
was focal PRL thinning over drusen compared to age-matched
controls, with drusen height having a much stronger corre-
lation than drusen width with the extent of PRL thinning over
drusen locations. Evaluation of drusen using SD-OCT is
currently underway on a larger scale in the age-related Eye
Disease Study 2 (AREDS-2) ancillary SD-OCT study, in high risk
drusen eyes with annual follow-up of up to 5 years.oss-sectional line scan image on Spectralis optical coherence
tion changes revealing drusen. (B) Cross-sectional Spectralis
geographic atrophy showing outer retinal atrophy with RPE
graphy image of left eye of a patient with exudative age-
tion with overlying retinal edema and subretinal fluid.
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[Fig. 6B], Fleckenstein et al. [26], have described the morpho-
logical patterns seen on SD-OCT by dividing them into three
zones: perilesional, junctional, and atrophic zones. On Spec-
tralis OCT, the perilesional zone reveals typical changes seen
in early AMD including drusen and RPE changes. At the
junctional zone, along with the above changes, there is loss of
overlying photoreceptors for some distance beyond the edge
or together with the RPE, with the ELM ending in a curved line.
There is loss of ONL as well with an attenuated OPL resting
directly on Bruch's membrane or the remaining sub-RPE de-
posits. Within the atrophic zone itself, islands with preserved
layers (i.e., RPE-, IPL-band, ELM, ONL, and OPL) were noted. In
another study by the same authors, swelling and widening of
visible structures at the foveal ONL was seen on Spectralis
OCT in patients with fovea spared geographic atrophy, which
they hypothesized, is a reflection of a preapoptotic stage of
neuronal cellular elements indicating imminent atrophy.
Margolis and Spaide [27], have proposed a novel enhanced
depth imaging (EDI) technique of imaging the RPE-Bruch'se-
choriocapillaris complex using Spectralis OCT. This is done by
positioning the scanner closer to the eye than the standard,
such that a stable inverted image is produced, with better
resolution of deeper layers, namely choroid. This new EDI
technique provides new evidence that pigment epithelial de-
tachments (PED), previously visualized as optically empty on
Stratus OCT has some sort of internal structure along the back
surface of the RPE. He proposes that this new evidence sup-
ports Gass' hypothesis that development of PED is associated
with an underlying choroidal neovascular membrane.
In patients with exudative AMD, SD-OCT by its ability to
yield high resolution 3D images, provides volumetric mea-
surements of choroidal neovascular membrane and is more
sensitive than Stratus OCT in identifying abnormalities such
as subretinal fluid and retinal edema [Fig. 6C]. Khurana et al.
[28], in their comparative study of FA, TD-OCT and SD-OCT
findings in patient with CNV noted that SD-OCT picked up
more than 90% of cases of CNV identified on FA compared to
59% on Stratus OCT. However, they cautioned that SD-OCT did
not identify all cases with fluorescein leakage from CNV, and
is accompanied by a decreased specificity, such that abnor-
malities might warrant consideration of retreatment (e.g.,
persistent cystoid abnormalities in the absence of fluorescein
leakage from CNV). Framme et al. [29], evaluated morpholog-
ical changes in CNV on SD-OCT after anti-VEGF monotherapy
in patients with exudative AMD to see if anti-VEGF therapy
caused CNV regression or stops further CNV growth. They
found that there was no change in CNV morphology on SD-
OCT after anti-VEGF treatment in over 80% of patients. Pa-
tients with classic CNV on fluorescein angiogram showed a
small change in the overall thickness of CNV with no change
in the diameter.Spectral-domain optical coherence tomography
in cystoid macular edema secondary to vein
occlusion
Imaging by OCT in CME due to retinal vein occlusions has
given an insight into the pathology of the condition. On TDStratus OCT, the location of cysts could not be correlated to
the corresponding layer in the retina and were grouped as
outer, or inner retinal cyst. On SD-OCT, Ota et al. [30],
observed that cysts in the fovea were located predomi-
nantly in the outer plexiform and inner nuclear layers,
whereas in the extra-foveal area, small cystoid spaces were
seen less frequently in the other retinal layers [Fig. 7A]. In
addition, they reported that discontinuity in the ELM layer
on the SD-OCT is a poor prognostic factor for visual
outcome in these patients. This has been observed by SD-
OCT in patients with other retinal pathologies, including
AMD and DME.
In patients with long standing CME, in cases due to retinal
vascular occlusion, a subfoveal sensory detachment is seen.
The pathophysiology of the sensory detachment is unknown
with underlying RPE pump disturbance due to ischemia sus-
pected to be the likely cause [31]. Ota et al. [31], have produced
new evidence on SD-OCT implicating tractional forces by the
expanding Muller's cells on the photoreceptors as the likely
etiology for the development of serous detachment [Fig. 7B].Spectral-domain optical coherence tomography
in plaquenil maculopathy
One of the novel applications of SD-OCT has been to identify
subclinical damage in the photoreceptors in patients on
chronic use of hydroxychloroquine. Chen et al. [32] first re-
ported abnormalities in the perifoveal photoreceptor ellipsoid
zone were seen on SD-OCT in asymptomatic patients on
hydroxychloroquine. In patientswho are asymptomatic, Chen
et al. [32], have reported that thinning of GCL and retinal NFL
precedes the involvement of outer retina and have suggested
the use of peripapillary RNFL thickness to monitor patients on
long-term hydroxychloroquine therapy.Spectral-domain optical coherence tomography
in central serous retinopathy
Central serous chorioretinopathy (CSR) is characterized by
serous detachment of the neurosensory retina and accumu-
lation of serous fluid, secondary to one ormore focal lesions of
the RPE [Fig. 8]. It is characterized by the presence of subretinal
fluid, and PED and accumulation of granular or fibrinous
material may accumulate in the subretinal cavity. Chronic
CSR, also known as diffuse retinal pigment epitheliopathy, is
seen with a prolonged period of PED and is associated with
photoreceptor atrophy and patches of irregularly pigmented
RPE. SD-OCT can demonstrate shallow serous detachments
that are difficult to diagnose using slit-lamp biomicroscopy or
Stratus OCT. SD-OCT provides precise information about the
amount and localization of subretinal fluid and RPE abnor-
malities in CSR. It also helps in determining a treatment plan.
SD-OCT is also useful in assessing whether reattachment has
occurred after treatment.
Ahlers et al. [33], have reported retinal changes during
acute phase of CSR. They found that SD-OCT assists in iden-
tifying the precise location of the PED and frequently found
multiple small PEDs without splitting or thickening of the RPE
Fig. 7 e (A) Spectralis angiography with corresponding cross-sectional optical coherence tomography image of a patient with
central retinal vein occlusion showing cystoid macular edema with cysts in outer plexiform and inner nuclear layer. (B)
Spectralis optical coherence tomography showing cystoid macular edema in a patient with central retinal vein occlusion
revealing inner retinal edema with stretched out Muller cell.
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they also observed an area of hyper-reflectivity in the level of
the ONL, sometimes affecting the OPL. They also found clus-
ters of punctate subretinal deposits of hyper-reflective mate-
rial in most patients. These deposits are thought to be
lipophilic fragments such as residuals of rhodopsin and/or
outer cone segments, present due to impaired RPE function. In
a study by Ojima et al. [34], they reported that a large defect ofFig. 8 e Spectralis optical coherence tomography image of a
patient with central serous retinopathy. Note the foveal
layers are intact with minimal disorganization.the outer segments in the foveal PRL correlated with poor vi-
sual acuity. In eyes with active CSR, however, the ellipsoid
zone is often nondetectable in the detached retina. They also
found that the restoration of ellipsoid zone in the subfoveal
portion of the reattached retina is associated with relatively
good visual acuity prognosis [34].
Spaide has previously reported the use of EDI OCT, in CSR.
The choroid in eyes with CSR was found to be much thicker
than normal. Maruko et al. [35], have reported the use of EDI-
OCT to show the decrease in choroidal thickness in patients
with resolved CSC treated with photodynamic therapy (PDT).
Chronic CSC may be difficult to differentiate from occult
choroidal neovascularization secondary to CSC.Spectral-domain optical coherence tomography
in macular telangiectasia
One of the characteristic findings of idiopathic macular tel-
angiectasia is cavitation of the inner retina in the foveola,
which Nowilaty et al. [36], have described as a draping of the
ILM across the foveola related to an underlying loss of tissue.
In addition, in their series, they have reported a lack of cor-
relation between retinal thickening onOCT and leakage on FA,
cyst-like structures in the foveola and within internal retinal
layers such as the inner nuclear or GCL and central intra-
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ported by Maruko et al. [37].Spectral-domain optical coherence tomography
in diseases of the vitreoretinal interface
Classic diseases of the vitreoretinal interface include vitre-
omacular traction (VMT), epiretinal membrane (ERM), and
macular holes (MH). Though first described in 1865 (Hassen-
stein), the advent of OCT has significantly enhanced our ability
to visualize and follow patients with this group of disease [38].Vitreomacular traction
Histopathologic analysis implicated epiretinal proliferation,
with and without membrane development, in the VMT [39],
which has been subsequently demonstrated in vivo by TD [38],
and SD-OCT [40]. SD-OCT affords enhanced resolution and
segmentation of the retina [6,11], where changes in PRL have
been functionally correlated with vision [Fig. 9]. SD-OCT
further allows for 3D documentation of VMT which can assist
in surgical planning and monitoring [40]. Recently, a 2 years
prospective study correlated the structural improvement of the
retina, documented by SD-OCT, with recovery of visual acuity
in patients following surgery for VMT.High-resolution imaging
provided by SD-OCT allowed for postoperative monitoring of
changes in retinal morphology. The authors reported a slower
improvement in inner and outer layers of the retina as
compared to surface irregularities, and a positive correlation
with these changes and best-corrected visual acuity.Epiretinal membrane
ERMareclinically evident inup to6%of thepopulation [41], and
consist of myofibroblasts, astrocytes, and fibrous astrocytes
[39]. Racial differences can affect the prevalence with higher
rates reported in the Latino population in America (29.9%) [42],
as compared to the Chinese population (39%). Idiopathic ERM's
are thought to result as a consequence of posterior vitreous
separationandcandevelop secondary tovitreoushemorrhage,
inflammatory disease [43], retinal vascular disease, and both
surgical and nonsurgical trauma. A recent Chinese populationFig. 9 e Spectralis optical coherence tomography revealing
partially detached posterior hyaloid with attachment to the
fovea leading to traction and cystic changes.based study that evaluated the presence of ERM using TD-OCT
revealed a prevalence of 3.0% based on fundus photography
alone and 3.4% based on the combination of photography and
OCT. This is the first study to document the prevalence of ERM
with the use of OCT and suggests that this imaging modality
may be able to demonstrate additional cases. Unfortunately,
no such large population based studies are available that
evaluate the prevalence of ERM using SD-OCT at this time. It is
likely that a higher prevalence will be reported comparedwith
TD-OCT, as it has been shown that SD-OCT is superior in
demonstrating ERM's [44]. Further, SD-OCT is more accurate
than TD-OCT in delineating epiretinal pathology from inner
retinal layers. 3D analysis of SD-OCT images has further
enhanced our understanding of the morphology of ERM's and
their relationship with the underlying retina [45]. A recent
prospective study, evaluated ultra-structural changes in the
outer retina and correlated them with visual improvement in
patients following membrane peeling using SD-OCT, over 3
months of follow-up. This kind of correlation can assist the
surgeon in predicting and monitoring functional outcomes in
patients with ERM's following membrane peeling [46].Macular holes
The incidence of MH increases with age and demonstrates
female predominance. MH can largely be categorized into two
groups: (1) Idiopathic and (2) traumatic, with idiopathic MH
[Fig. 10A and B] being five timesmore common than traumatic
MH. Other associations including ocular (CME, neodymium-
doped yttrium aluminum garnet-laser, surgery) and sys-
temic conditions have been reported. Proposed theories con
the vitreoretinal interface have been reported for both idio-
pathic and traumatic MHs [47]. Only few reports in the liter-
ature exist on application of OCT in traumatic MH. TD-OCT
has been used to describe the morphologic features of trau-
maticMH [48], and to compare themwith idiopathicMH [49]. It
appears from the lack of literature, the greatest application of
SD-OCT is in evaluation and management of idiopathic MH.
It has been previously established that SD-OCT affords
greater segmentation analysis and details of the outer retina as
compared to traditional TD-OCT [9,12,44]. SD-OCT has been
showntodemonstratephotoreceptorouter-segmentdisruption
and that this correlated with reduced visual acuity in patients
with idiopathic MH [50]. Subsequently, independent retrospec-
tive studies evaluated the pre- and post-operative changes in
SD-OCT to provide prognostic information to patients under-
going vitrectomy for idiopathicMH based on the characteristics
of the disruption in inner and outer retinal segments [51]. Thus,
ultra-structural retinal changesvisualizedbySD-OCTareuseful
in counseling patients on potential visual recovery following
closureof idiopathicMH. Further studiesare required toprovide
such information in the cases of traumatic MH.Spectral-domain optical coherence tomography
in intra-ocular tumors
Choroidal nevus is commonly found and only a small number
undergo malignant transformation. While evaluating small
Fig. 10 e (A) Spectralis optical coherence tomography cross-
sectional image of a patient with inner lamellar macular
hole. There is a tractional component with an epiretinal
membrane seen nasally. (B) Spectralis optical coherence
tomography cross-sectional image of a full-thickness
chronic macular hole. There are cystic changes in the retina
with elevation of the edges of the hole by subretinal fluid.
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rogate for melanoma. In addition to quantitative features
(size: Basal diameter and height) several qualitative features
such as the presence of orange pigment, subretinal fluid and
absence of drusen predict risk of growth of choroidal mela-
nocytic lesions. These factors are now well established to
indicate prognostic significance of the melanoma and are
amenable to assessment by SD-OCT. However, due to limited
tissue penetration SD-OCT does not detect significant differ-
ences in the internal characteristics of the choroidal tumors.
The presence or absence of drusen, SRF was based on an
analysis of SD-OCT images centered on themelanocytic lesion,Fig. 11 e Spectralis optical coherence tomography cross-sectiona
mass with overlying serous retinal detachment of the macula.while orange pigment was identified as focal hyper-
autofluorescent spots on FAF imaging. This was studied by
Singh et al. [52], and they found no statistically significant dif-
ference indetectionratesofdrusen, subretinalfluid,andorange
pigment between ophthalmoscopic examination and SD-OCT.
Choroidal hemangioma is a vascular hamartoma that oc-
curs sporadically, in a circumscribed isolated form, or as a
diffuse choroidal angiomatosis. On SD-OCT, choroidal hem-
angioma, the mass itself is imaged with limited resolution
with an area of hyper-reflectivity on its anterior surface. On
SD-OCT it may appear as a dome shaped elevation of the
choroid and focal hyper-plasia of the overlying RPE and retinal
serous detachment [Fig. 11]. Imaging the overlying retina is
useful to determine the etiology for the vision loss. The tumor
may remain clinically stable or show enlargement or pro-
gressive exudation leading to CME and SRF and subretinal
fibrosis which may induce vision loss. Presence of these fac-
tors usually mandates treatment. Treatment modalities may
include laser, brachytherapy or more recently PDT.
SD-OCT is an important tool in depicting resolution of
subretinal fluid and foveal edema following therapy. Addi-
tionally, SD-OCT can be useful in planning the treatment and
prognosticating the final visual outcome following treatment
for circumscribed choroidal hemangiomas. We have recently
reported a case of a patient with choroidal hemangioma
treated with PDT [53]. We noted resolution of intra-retinal
edema, resolution of SRF, and disappearance of RPE changes
on SD-OCT.
Combined hamartoma of the retina and RPE is a rare dis-
order diagnosedmainly in infants and young children. It could
be asymptomatic or characterized by visual acuity loss, stra-
bismus. Clinically the lesion is typically juxtapapillary or pe-
ripheral in location. The juxtapapillary lesions have variable
pigmentation, are elevated, have vascular tortuosity, have
vitreoretinal interface changes with ERM and lipid exudates.
Peripheral lesions appear as an elevated gray ridge concentric
to the ora serrata that may produce dragging of the large
retinal vessels. Differential diagnosis of this lesion includes
choroidal nevus and choroidal melanoma. Vitreo-retinal
interface change is likely and is responsible for vision loss in
some patients; it is well imaged by SD-OCT. All these findings
may help with surgical intervention. On SD-OCT the lesion
has been described as a hyper-reflective ERM with traction
and retinal folds. Within the retina it appears as an elevated
hyper-reflective mass with an underlying attenuation of the
outer retina and PRL. Themass appears to be disorganized andl image of choroidal hemangioma revealing the choroidal
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unique OCT characteristics highlighted with the newer-
generation high-resolution instruments, which may be
necessary in both diagnosis and surgical planning.Fig. 12 e Spectralis optical coherence tomography of a
patient with advanced Stargardt's disease revealing foveal
atrophy with surrounding flecks.Spectral-domain optical coherence tomography
in inherited retinal disorders
Even though SD-OCT has been used in the ophthalmic com-
munity for the past decade, we are just beginning to under-
stand its value in the evaluation of a number of inherited
retinal diseases, including Stargardt's disease, Best's disease,
Adult-onset foveomacular vitelliform dystrophy (AOFVD),
retinitis pigmentosa, and cone dystrophy. Before any macular
pathology is visible on fundus examination, SD-OCT allows us
to identify the pattern and the extent of the neurosensory
retinal disorganization in terms of RPE and photoreceptor cell
loss in these dystrophies.Stargardt's disease
Described by Stargardt in 1909, it is a bilateral symmetric
maculopathy, characterized by the presence of a variable
number of fish-scale shaped, yellowish, autofluorescent de-
posits [54]. OCT anomalies occur very early in Stargardt disease
including loss of the foveal clivus, discontinuity or loss of the
PRL, and retinal thinning. The retinal flecks have an appear-
ance of hyper-reflective deposits opposed to the pigment
epithelium, or rarely, further away in theONL. Type 1 flecks are
dome-shaped deposits located within the RPE and the outer
segment of photoreceptors. Type2flecks are deposits involving
the ONL as well. They are encountered in advanced or severe
stages, with the loss of the PRL within the central foveal zone,
ultimately leading to foveal atrophy [Fig. 12].Fig. 13 e Spectralis optical coherence tomography of a patient
with Best disease showing buildup of lipofuscin, between the
outer retina and the retinal pigment epithelium.Best disease
Vitelliform macular dystrophy, also known as Best disease,
was described by Friedrich Best in 1905. Most cases have a
solitary lesion in the macula; others have multifocal vitelli-
form lesions, which are largely confined to the posterior pole
[Fig. 13]. Querques et al. [55], based on SD-OCT scans,
described the macular lesions as follows: (1) Previtelliform
lesions, characterized by the presence of a layer between the
RPE and the photoreceptor ellipsoid zone interface, corre-
sponding to the Verhoeff membrane, which appears thicker
and more reflective in the central region than the normal
macula; (2) Vitelliform lesions, characterized by the yellowish
material that appears as a highly reflective area, located be-
tween the hypo-reflective ONL and the hyper-reflective RPE
layer. Also, focal disruption of ellipsoid zone interface over the
lesion is present; (3) Pseudohypopyon lesions, characterized
by two different zones-in the upper part of the lesion, SD-OCT
showed an optically empty zone (hypo-reflectivity) with
clumping of hyper-reflective material on the posterior retinal
surface, located between the RPE and the photoreceptor
ellipsoid zone interface. In the lower part of the lesion, wherethe material is still visible, in SD-OCT showed the yellowish
material that appears as a highly reflective area, located be-
tween the hypo-reflective ONL and the hyper-reflective RPE
layer, comparable with the vitelliform lesion; (4) Vitelliruptive
lesions, characterized by an optically empty lesion with
clumping of hyper-reflective material on the posterior retinal
surface, located between the RPE and the photoreceptor
ellipsoid zone interface, comparablewith the upper part of the
pseudohypopyon; (5) Atrophic lesions, characterized by thin-
ning of all the retinal layers and diffuse loss of the ellipsoid
zone interface (complete absence of the hyper-reflective layer
corresponding to the ellipsoid zone interface) within the
macular area, with enhanced RPE reflectivity; (6) Fibrotic le-
sions, characterized by a prominent, highly hyper-reflective
thickening at RPE level, inducing marked anterior bulging,
accompanied by thinning of the sensory retina and diffuse
loss of the ellipsoid zone interface above it.Adult-onset foveomacular vitelliform dystrophy
adult-onset foveomacular vitelliform dystrophy
AOFVD is a relatively uncommon macular disease first
described by Gass [56], in 1974. Fundus examination shows a
b i om e d i c a l j o u r n a l 3 9 ( 2 0 1 6 ) 1 0 7e1 2 0 117subretinal oval or round elevated deposit of yellowish vitelli-
form material located in the macular area [Fig. 14]. The exact
location of the vitelliformmaterial in AOFVDhas not been fully
elucidated by previous clinical or histological descriptions.
Puche et al. [57], with the help of SD-OCT showed the vitelli-
form material as a highly reflective dome-shaped lesion
located between the PRL and RPE. In their study, the vitelliform
material appeared homogeneous in 14/60 eyes and heteroge-
neous in 36/60 eyes. An optically empty zone between the PRL
and thematerial, and/or the RPE layerwas observedwithin the
hyper-reflective vitelliform lesion in 29/60 eyes. The ellipsoid
zone interface appeared highly reflective, showing a shell-like
aspect all around thevitelliformmaterial in 27/60 eyes. TheRPE
was found to be irregular with hyper-reflective mottling with
discrete RPE detachments seen in 29/60 eyes.Retinitis pigmentosa
RP is a group of inherited disorders characterized by progres-
sive peripheral vision loss and night vision difficulties that can
lead to central vision loss by progressive degeneration of the
photoreceptors. OCT can identify vitreoretinal abnormalities
associated with RP that often contribute to the deterioration of
visual acuity in these patients [58]. In RP, SD-OCT reveals lossFig. 14 e Spectralis optical coherence tomography of a
patient with adultonset foveo-macular vitelliform dystrophy
revealing accumulation of vitelliform material between the
and neuro-sensory retina.
Fig. 15 e Spectralis optical coherence tomography of a patient with
and external limiting membrane.of the ellipsoid zone at one or more peripheral locations from
early stages followed by overall marked reduction of the total
retinal thickness. Aizawa et al. [59], showed ellipsoid zone
junction to be absent in 5e31% of the cases. Triolo et al. [58],
found that the ellipsoid zone junction was either absent or
disrupted within the foveal region in 13.6% and 47.7% of cases,
respectively. CME macular edema, if present, is very easily
seen on SD-OCT even though it doesn't leak on fluorescence
angiography. ERM is seen as a hyper-reflective membrane on
the surface of the retina [Fig. 15].Cone dystrophy
The progressive cone dystrophies represent a heterogeneous
group of diseases with onset in teenage years or later adult life
[60]. Many patients develop rod photoreceptor involvement in
later life, leading to considerable overlap between progressive
cone and cone-rod dystrophies. Cone dystrophies are diag-
nosed by an abnormal or nonrecordable photopic electroreti-
nogram (ERG) and a normal or near-normal rod-isolated ERG,
whereas peripheral visual fields remain normal. SD-OCT
finding may be recognized before any pathology becomes
evident on fundus examination. The loss of photoreceptors
predominates in the foveolarorperifoveolar zonesgiving rise to
the classic bull's eye pattern. Absence of ellipsoid zone junction
and RPE gives rise to the hyper-reflective signal of the choroid.Retinoschisis
Degenerative or acquired retinoschisis (RS) is a split in the
neurosensory retina, which is usually asymptomatic, rarely
progressive, but often presents a diagnostic dilemma on
routine dilated funduscopy. Inner and outer schisis cavity
appeared to be separated by the OPL [61]. The irregularity of
the inner surface of the attached outer leafwas identified in all
RS patients [61].Spectral-domain optical coherence tomography
in retinopathy of prematurity
Retinopathy of prematurity (ROP) is a multifactorial vascular
disease and timely treatment of ROP is important to preventretinitis pigmentosa with associated cystoid macular edema
b i om e d i c a l j o u r n a l 3 9 ( 2 0 1 6 ) 1 0 7e1 2 0118disease progression and improve visual outcomes. SD-OCT is
also been tried to assess the macular and retinal changes in
the premature retina, allowing detection of subclinical
anatomic changes in infants, although data on its use in ROP
screening are limited. Maldonado et al. [62], have reported
CME as a common finding in their cohort of premature babies,
which did not differ by race and when present, was almost
always bilateral. Increased severity of CME, identified by, was
associated with subsequent laser treatment, with plus disease
and with higher ROP stage. Chavala [63], and coworkers have
reported the use of hand held SD-OCT for the assessment of
retina in ROP babies, which can be done in neonatal intensive
care settings. Wu et al. [64], reported retention of the layer of
retinal ganglion cells, IPL, and inner nuclear layer in ROP ba-
bies who needed treatment in form of laser or cryotherapy.Miscellaneous
Although OCT has beenwidely employed in retinal diseases, it
is also important to mention the application of OCT in
choroidal diseases and in myopia.
In patients with high axial myopia, there can be associated
degenerative changes in the sclera, choroid, and retina
involving the macula [65]. Common macular changes in
highly myopic eyes are maculoschisis, posterior vitreous
detachment, disruption of the photoreceptor ellipsoid zone
interface, ERMs, defects in Bruch'smembrane, clumping of the
RPE, vitreofoveal adhesion, and MH [65]. Majorities of these
changes are structural and can be clearly delineated using
different OCT techniques. Changes like disruption of the
ellipsoid zone and ERM formation can have a functional
impact by negatively affecting the visual acuity [65].
In the past, insight into the majority of choroidal diseases
has been through histological postmortem studies or invasive
methods such as indocyanine green angiography and FA [66].
However, with the advent of EDI-OCT [66] and more recently
swept source OCT (SS-OCT) [67], we can obtain in vivo 3D
anatomical information about the choroid. SS-OCT employs a
longerwavelength (1080 nm)which enables it to have a deeper
penetration of ocular tissues beyond the photoreceptor and
RPE layers, allowing visualization of choroidescleral junction.Conclusion
SD-OCThas evolvedover adecadeasoneof themost important
diagnostic tools in ophthalmology. It not only helps us in diag-
nosing the retinal and choroidal pathologies but also guides us
in monitoring the response to treatment. Now with advanced
OCT (EDI- and SS-OCT) better deeper visualization is possible.
There are opportunities for new directions in research and
clinical practice with ongoing evolution of OCT technology and
easier availability to the clinicians and researchers.Source of support
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